Clinical Trial Update: Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery : Revised Protocol [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial on intravenous L-Citrulline in children undergoing heart bypass surgery completed phase 1/2 with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Septal Defect
• Atrioventricular Septal Defect
• Ventricular Septal Defect

Drugs mentioned

• L-citrulline (L-citrulline)

Snippet

Sponsor: Asklepion Pharmaceuticals, LLC | Conditions: Atrial Septal Defect, Ventricular Septal Defect | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-06-21